Atlas Trials

Muscular Dystrophy, Duchenne Type

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Muscular Dystrophy, Duchenne Type

RecordFirmDate
Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO) (NCT07608432)Dyne Therapeutics2026-06-01
Trunk Oriented Exercises Versus Whole-body Vibration for Duchenne Muscular Dystrophy (NCT05688072)Cairo University2023-01-15

Track Muscular Dystrophy, Duchenne Type automatically

Every clearance here is in the API, with alerts when new ones post.